1. Sourbron, Jo, Jansen, Katrien, Mei, Davide, Guerrini, Renzo, Lagae, Lieven. 2021. SLC7A3: In Silico Prediction of a Potential New Cause of Childhood Epilepsy. In Neuropediatrics, 53, 46-51. doi:10.1055/s-0041-1739133. https://pubmed.ncbi.nlm.nih.gov/34872132/
2. Wang, Peng, Song, Yihui, Li, Hongyu, Ma, Mengjun, Shen, Huiyong. 2023. SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake. In Cancer letters, 576, 216412. doi:10.1016/j.canlet.2023.216412. https://pubmed.ncbi.nlm.nih.gov/37769797/
3. He, Lifang, Xu, Yue, Lin, Jiediao, Lin, Stanley Li, Cui, Yukun. . Increased SLC7A3 Expression Inhibits Tumor Cell Proliferation and Predicts a Favorable Prognosis in Breast Cancer. In Recent patents on anti-cancer drug discovery, 20, 55-70. doi:10.2174/0115748928279007231130070056. https://pubmed.ncbi.nlm.nih.gov/38204267/
4. Yan, Yuhan, Chen, Chao, Li, Zhiguo, Park, Narin, Qu, Cheng-Kui. 2022. Extracellular arginine is required but the arginine transporter CAT3 (Slc7a3) is dispensable for mouse normal and malignant hematopoiesis. In Scientific reports, 12, 21832. doi:10.1038/s41598-022-24554-2. https://pubmed.ncbi.nlm.nih.gov/36528691/
5. Lowman, Xazmin H, Hanse, Eric A, Yang, Ying, Li, Haiqing, Kong, Mei. . p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake. In Cell reports, 26, 3051-3060.e4. doi:10.1016/j.celrep.2019.02.037. https://pubmed.ncbi.nlm.nih.gov/30865893/
智鼠故事 
